Aryl ureas with angiogenesis inhibiting activity

作者: Holia Hatoum-Makdad , James Elting , William J. Scott , Jacques Dumas

DOI:

关键词:

摘要: This invention relates to methods of using aryl ureas treat diseases mediated by the VEGF induced signal transduction pathway characterized abnormal angiogenesis or hyperpermeability processes.

参考文章(636)
Josef Geisenberger, Hans-Tobias Macholdt, Andreas Harz, Ruediger Baur, Heidemarie Menzel, Eduard Michel, Use of improved cyan pigments in electrophotographic toners and developers, powder coatings and inkjet inks ,(2000)
Herbert Dung, Emil Elsner, Direct current-light arc furnace ,(1991)
P. Lissoni, F. Rovelli, F. Malugani, F. Brivio, L. Fumagalli, G.S. Gardani, Changes in circulating VEGF levels in relation to clinical response during chemotherapy for metastatic cancer International Journal of Biological Markers. ,vol. 18, pp. 152- 155 ,(2003) , 10.5301/JBM.2008.1731
Paul W Sternberg, José Alberola-Ila, Conspiracy theory: RAS and RAF do not act alone. Cell. ,vol. 95, pp. 447- 450 ,(1998) , 10.1016/S0092-8674(00)81612-8
Timothy B Lowinger, Roger A Smith, Jacques Dumas, Recent developments in the discovery of protein kinase inhibitors from the urea class. Current Opinion in Drug Discovery & Development. ,vol. 7, pp. 600- 616 ,(2004)
Jacques Dumas, Protein kinase inhibitors from the urea class. Current Opinion in Drug Discovery & Development. ,vol. 5, pp. 718- 727 ,(2002)
Junichi Kikuta, Hiroshi Matoba, Hiroyoshi Koyama, Uncoated tablets and method of producing the same ,(1994)
K. Moelling, B. Strack, G. Radziwill, Signal Transduction as Target of Gene Therapy Recent results in cancer research. ,vol. 142, pp. 63- 71 ,(1996) , 10.1007/978-3-642-80035-1_5
R Bucovec, P Lissoni, A Bonfanti, F Malugani, L Vigoré, F Brivio, R Ferrante, F Rovelli, S Viviani, M Mandalà, S Secondino, A Ferrari-Bravo, L Fumagalli, G S Gardani, Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1. Journal of Biological Regulators and Homeostatic Agents. ,vol. 15, pp. 140- 144 ,(2001)
N S Magnuson, U Smola, H Vahidi, H Hahn, T Beck, U R Rapp, The Raf-1 serine/threonine protein kinase Seminars in Cancer Biology. ,vol. 5, pp. 247- 253 ,(1994)